Cognitive Performance Assessment
A structured screen of attention, memory, and related skills. It is not a dementia or ADHD diagnosis. Progressive decline needs licensed medical referral, not repeat wellness testing.
A structured screen of attention, memory, and related skills. It is not a dementia or ADHD diagnosis. Progressive decline needs licensed medical referral, not repeat wellness testing.
A cognitive performance assessment is a structured look at attention, memory, processing speed, and executive skills, usually paired with sleep, mood, medicine, sensory, and daily-function history. It can establish a reproducible baseline. It is not the same as diagnosing dementia, mild cognitive impairment, ADHD, concussion, or another neurologic disease. Screening is not diagnosis. Scores vary with practice effects, language, education, fatigue, pain, anxiety, and testing conditions.
NIA materials distinguish ordinary aging-related change from impairment that interferes with independence. Clinician pages on assessing cognitive impairment in older patients emphasize validated tools in the right context, a search for reversible contributors, and follow-up—not a one-time wellness printout. The AAN mild cognitive impairment guideline says clinicians should use validated tools when assessment is appropriate, evaluate function and modifiable risks, and monitor over time. That pathway belongs in licensed medical or neuropsychological care when results are concerning.
Computerized batteries sold in longevity clinics may be useful as aids if the instrument, version, and limitations are documented. Some products are FDA-classified as computerized cognitive assessment aids with a defined intended use. That classification does not authorize an app to diagnose Alzheimer disease or to replace a neurologic examination. Consumer “brain age” scores are even further from a medical test. Progressive decline, lost daily function, focal neurologic symptoms, or a clearly abnormal screen should lead to primary-care, neuropsychology, or neurology referral rather than another paid wellness repeat.
This page is for people offered a baseline or “optimization” test. It does not rank clinics and it does not assign a disease from a single session. Prefer a physician, nurse practitioner, physician assistant, or neuropsychologist when the question is diagnosis. Keep emergency care for sudden confusion, weakness, speech change, seizure, or a sudden severe headache.
Bring glasses or hearing aids, a medicine and supplement list, and any prior test reports. Sleep as normally as you can and avoid unusual caffeine, alcohol, or all-night work before testing. Tell the examiner about pain, fever, or a recent night without sleep. If decline is already obvious to family, schedule a medical visit; do not use this assessment as the only next step.
There is no physical downtime. Testing can be tiring or anxiety-provoking. Avoid high-stakes life decisions from a single poor session. If results are abnormal or function is slipping, the next step is licensed follow-up, not another cash retest the same week. Sudden neurologic symptoms after you leave are unrelated to “recovery” and need emergency care.
The main risks are misclassification, anxiety, false reassurance, and unnecessary repeat testing. Computer scores must not replace clinical evaluation. Practice effects can mimic improvement. Language, education, and fatigue can mimic impairment. Sudden confusion, new weakness, speech change, severe headache, seizure, or rapidly progressive decline needs urgent medical assessment. Delay of that care while a clinic sells serial wellness screens is the avoidable harm.
NIA: Assessing Cognitive Impairment in Older Patients
https://www.nia.nih.gov/health/health-care-professionals-information/assessing-cognitive-impairment-older-patientsNIA: How the Aging Brain Affects Thinking
https://www.nia.nih.gov/health/brain-health/how-aging-brain-affects-thinkingPMC: AAN Practice Guideline Update—Mild Cognitive Impairment
https://pmc.ncbi.nlm.nih.gov/articles/PMC5772157/NIMH: Attention-Deficit/Hyperactivity Disorder (ADHD)
https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhdFDA: Computerized Cognitive Assessment Aid (21 CFR 882.1470)
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?id=PTY© 2026 Longevity Clinic Finder. All rights reserved.
Designed by SMBPulse
Adults seeking a performance baseline who do not have acute neurologic symptoms and who accept that the visit is a screen, not a diagnosis. People with progressive decline, lost daily function, or a concerning screen need medical or neuropsychological referral rather than another optimization test.
Explore nearby clinics, compare profiles, and find providers offering this treatment.
Find Clinics Near You© 2026 Longevity Clinic Finder. All rights reserved.
Designed by SMBPulse